Luminopia
Signal active
Organization
Contact Information
Overview
Luminopia develops a new class of treatments for significant neuro-visual disorders. The company is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, to treat amblyopia, the cause of vision loss among children.
About
Industries
Virtual Reality, Health Care, Medical
Founded
2015
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Luminopia headquartered in United States, North America, operates in the Virtual Reality, Health Care, Medical sector. The company focuses on Virtual Reality and has secured $2.0B in funding across 60 round(s). With a team of 11-50 employees, Luminopia is actively contributing to advancements in Virtual Reality. Their latest funding round, Series A - Luminopia, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
4
Lead Investors
0
Total Funding Amount
$33.1M
Details
5
Luminopia has raised a total of $33.1M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 4.8M | ||
| 2019 | Seed | 5.7M | ||
| 2022 | Seed | 5.7M | ||
| 2023 | Early Stage Venture | 16.0M |
Investors
Luminopia is funded by 21 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Luminopia | - | FUNDING ROUND - Luminopia | 16.0M |
| U.S. Venture Partners | - | FUNDING ROUND - U.S. Venture Partners | 16.0M |
| Luminopia | - | FUNDING ROUND - Luminopia | 16.0M |
| Broadfin Advisors | - | FUNDING ROUND - Broadfin Advisors | 16.0M |
Recent Activity
There is no recent news or activity for this profile.